CTRI/2022/03/041406招募中2 期
A Prospective, Single centric, Phase II, Randomized, Double-blind, Placebo-controlled clinical Study to Evaluate the Safety and immune boosting efficacy of Siddha Drug Amukkara Churanam (AC) in SARS- CoV-2 (COVID-19) Infection among High risk group people. - AC_IMMUNE_trial
试验速览
- 阶段
- 2 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Presently not affected with COVID-19 infection or its possible symptoms
- •Adult Male or Female subjects above the age of 18 to 60 years.
- •After one month of COVID Vaccination
- •After three months of COVID Infection
- •The people who have not been vaccinated shall also be recruited in the trial. However, these participants would not be denied of the COVID-19 vaccination at any point of time during the trial.
- •Subjects who are at work for at least past 6 months in the health care facility where confirmed cases are identified and treated.
- •Willing and able to comply with survey completion, scheduled visits, treatment plan, and other study procedures
- •Subjects who are Competent and capable to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study
排除标准
- •Currently hospitalized
- •Symptomatic with subjective fever, cough, or sore throat
- •Patients with other systemic malignant diseases
- •any medical or surgical condition
- •Concomitant use of any other significant medications/ chemoprophylaxis
- •immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc.
研究者
相似试验
招募中
1 期
A Phase I/IIa, Prospective, Mono-center, Randomized, Open Labeled, Controlled Study to Assess the Safety and Efficacy of Applying Iloprost Locally in the Fracture Site to Promote Bone Healing in Patients With Proximal Humeral FractureProximal humeral fractureDRKS00027081Campus Virchow-KlinikumAugustenburger Platz 113353 BerlinCharité Campus Charité Mitte30
进行中（未招募）
不适用
A PHASE 2, SINGLE-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF ZOLEDRONATE IN SUBJECTS WITH EROSIVE HAND OSTEOARTHRITIS - ZOLEHOErosive hand osteoarthritisMedDRA version: 12.1Level: LLTClassification code 10019115Term: Hand osteoarthritisEUCTR2010-019110-24-DEniversitätsklinikum Erlangen
进行中（未招募）
不适用
nderstanding immunity after typhoid vaccinatioProphylaxis for Salmonella enterica serovar Typhi (S. Typhi) diseaseMedDRA version: 14.0Level: LLTClassification code 10039446Term: Salmonella typhi infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-003653-26-GBClinical Trials and Research Governance36
终止
1 期
A Phase 1/2 Single Center, Randomized, Double-blind, Placebo-controlled, Left-Right Comparison Study to Evaluate the Safety and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in Older Adolescents and Adults with at least Moderate Atopic DermatitisACTRN12607000447459eosil Inc.15
已完成
不适用
A PHASE I, SINGLE-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, SINGLE- AND MULTIPLE ASCENDING-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF GRC 10693 IN HEALTHY MALE SUBJECTSChronic neuralgia10034606NL-OMON33904Glenmark Pharmaceuticals SA.96